High precision photon radiotherapy of head and neck tumors by means of an integrated stereotactic and 3D planning system

Author(s):  
G. Gademann ◽  
W. Schlegel ◽  
G. Becker ◽  
J. Romahn ◽  
K.H. Höver ◽  
...  
1995 ◽  
Vol 20 (2) ◽  
pp. 111-115 ◽  
Author(s):  
A. Rovirosa ◽  
J. Berenguer ◽  
A. Sánchez-Reyes ◽  
B. Farrus ◽  
F. Casas ◽  
...  

2018 ◽  
Vol 24 (1) ◽  
pp. 25-31
Author(s):  
Noushin Hassan Pour ◽  
Alireza Farajollahi ◽  
Masoud Jamali ◽  
Ahad Zeinali ◽  
Amir Ghasemi Jangjou

AbstractIntroduction: Due to the effect of radiation on both the tumor and the surrounding normal tissues, the side effects of radiation in normal tissues are expected. One of the important complications in the head and neck radiotherapy is the doses reached to the larynx and spinal cord of patients with non-laryngeal head and neck tumors.Materials and Methods: In this study, CT scan images of 25 patients with non-laryngeal tumors including; lymph nodes, tongue, oropharynx and nasopharynx were used. A three-field and a four-field treatment planning with and without laryngeal shield in 3D CRT technique were planned for each patient. Subsequently, the values of Dmin, Dmean, Dmax and Dose Volume Histogram from the treatment planning system and NTCP values of spinal cord and larynx were calculated with BIOPLAN and MATLAB software for all patients.Results: Statistical results showed that mean values of doses of larynx in both three and four-field methods were significantly different between with and without shield groups. Comparison of absorbed dose didn’t show any difference between the three and four field methods (P>0.05). Using Shield, just the mean and minimum doses of spinal cord decreased in both three and four fields. The NTCP of the spinal cord and larynx by three and four-field methods with shield in the LKB and EUD models significantly are less than that of the three and four fields without shields, and in the four-field method NTCP of larynx is less than three radiation field.Conclusion: The results of this study indicate that there is no significant difference in doses reached to larynx and spinal cord between the treatments techniques, but laryngeal shield reduce dose and NTCP values in larynx considerably.


Oral Oncology ◽  
2021 ◽  
Vol 114 ◽  
pp. 105145
Author(s):  
Charlotte Benoit ◽  
Daniel Orbach ◽  
Stacy Cyrille ◽  
Kahina Belhous ◽  
Véronique Minard-Colin ◽  
...  

2020 ◽  
Vol 36 (1) ◽  
Author(s):  
Ahmed Abdullah Hamd ◽  
Essam Abd El-Wanes Behiry ◽  
Adel Tharwat Atallah ◽  
Sherif Maher Elaini ◽  
Ahmed Hamdy Alshafai

Abstract Background Nowadays, radiotherapy is widely used in management of many types of tumors including head and neck tumors; in this study, we concerned with its reverse effects on the Eustachian tube functions and if this effect is temporary or permanent. Results The whole (30) patients have tympanogram at both ears before starting radiotherapy; all patients (100%) were normal. In the immediate post radiotherapy tympanogram at the contralateral side, 6.7% of patients had effusion, and 20% had Eustachian tube dysfunction, while at the ipsilateral side, 20% of patients had effusion, and 33.3% had ET dysfunction. In the follow-up tympanogram 12 weeks post radiotherapy, we found that 6.7% of patients had effusion, and (10%) had Eustachian tube dysfunction at the contralateral side, while 6.7% of patients had effusion, and only 20% had Eustachian tube dysfunction at the ipsilateral side. Conclusion From this study, we concluded that patients with head and neck tumors treated by radiotherapy (apart from the nasopharynx) have a high incidence of affection of Eustachian tube function namely middle ear effusion and Eustachian tube dysfunction. The possibility for development of middle ear effusion and Eustachian tube dysfunction increases with increased tumor stage. Eustachian tube functions immediately post radiotherapy and after 12 weeks of the end of radiotherapy was affected by different effects according to the tumor site. The Eustachian tube functions significantly improved within 12 weeks after the last dose of radiotherapy, and we recommend audiological follow-up for patients with head and neck tumors treated with radiotherapy.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Steve Durante ◽  
Vincent Dunet ◽  
François Gorostidi ◽  
Periklis Mitsakis ◽  
Niklaus Schaefer ◽  
...  

1990 ◽  
Vol 83 (6) ◽  
pp. 923-929
Author(s):  
Yoichi Ogata ◽  
Toru Sekitani ◽  
Takaaki Noguchi ◽  
Yoichi Masumitsu ◽  
Hiroaki Shimogori ◽  
...  

1994 ◽  
Vol 31 ◽  
pp. S30
Author(s):  
L.E.C.M. Blank ◽  
P.F. Schouwenburg ◽  
D. González González ◽  
J.B. De Boer ◽  
P.A. Voûte ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document